BIOCONNECTION
LIVE

Serial Number

79358195

Owner

BioConnection B.V.

Attorney

E. Anthony Figg

Filing Date

Apr 26, 2023

Add to watchlist:

No watchlists yet
View on USPTO

BIOCONNECTION Trademark

Serial Number: 79358195 • Registration: 7574608

BIOCONNECTION is a trademark filed by BioConnection B.V. on April 26, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

BioConnection B.V.

Kloosterstraat 9,

Entity Type: 26

Trademark Details

Filing Date

April 26, 2023

Registration Date

November 26, 2024

Published for Opposition

June 25, 2024

Goods & Services

Business consultancy services relating to manufacturing of medicinal and pharmaceutical preparations; business management advice relating to manufacturing business; advertising services; business management

Medicines and pharmaceutical preparations, namely, for treatment of cardiovascular disorders, for treating diabetes, for treating allergies, for treating hypertension, for treating asthma, for use in urology, for use in dermatology, for treating skin disorders, for peripheral nervous system, for use in chemotherapy, for the treatment of hyperlipidemia, for the central nervous system, for treatment of infectious diseases, for the treatment of viral diseases, for the treatment of autoimmune diseases, for the treatment of musculo-skeletal disorders, for the treatment of gastro-intestinal diseases, for the treatment of immune system related diseases and disorders, kidney diseases or disorders, and diabetes; dietary supplements for humans and animals

Product research and development; research and development in the pharmaceutical and biotechnology field; research and development of new products for others; development of pharmaceutical preparations and medicines; services of bio technical, chemical and pharmaceutical laboratories, including scientific and technological research relating to the production of chemicals and biotechnological products for use in preparing pharmaceutical and veterinary preparations, as well as providing expert advice in the field of pharmaceutical and veterinary preparations; carrying out early evaluations in the field of new medicines as part of scientific research; development of pharmaceutical preparations, medicines and medicaments; evaluation of pharmaceutical products as part of scientific analysis and research; research and development in the pharmaceutical field; advice regarding the aforesaid research, development and analysis services as part of consultations about medicines; advice regarding scientific research and analysis relating to medicines; information with regard to scientific research in the field of biochemistry and biotechnology; scientific research, including in the medical sector

Contract manufacturing services in the field of preparing medicines and pharmaceutical products; custom manufacturing of biopharmaceuticals; custom manufacturing of pharmaceutical products, namely, for treatment of cardiovascular disorders, for treating diabetes, for treating allergies, for treating hypertension, for treating asthma, for use in urology, for use in dermatology, for treating skin disorders, for peripheral nervous system, for use in chemotherapy, for the treatment of hyperlipidemia, for the central nervous system, for treatment of infectious diseases, for the treatment of viral diseases, for the treatment of autoimmune diseases, for the treatment of Musculo-skeletal disorders, for the treatment of gastro-intestinal diseases, for the treatment of immune system related diseases and disorders, kidney diseases or disorders, and diabetes; preparing medicines and pharmaceutical products being contract manufacturing services, also with the aid of biotechnology

Chemical additives for use in manufacturing of pharmaceuticals; chemical additives for use in the manufacture of medicaments; chemicals used in industry and science; active chemical ingredients for use in the manufacture of pharmaceuticals for treating cardiovascular disorders, for treating diabetes, for treating allergies, for treating hypertension, for treating asthma, for use in urology, for use in dermatology, for treating skin disorders, for peripheral nervous system, for use in chemotherapy, for the treatment of hyperlipidemia, for the central nervous system, for treatment of infectious diseases, for the treatment of viral diseases, for the treatment of autoimmune diseases, for the treatment of musculo-skeletal disorders, for the treatment of gastro-intestinal diseases, for the treatment of immune system related diseases and disorders, kidney diseases or disorders, and diabete

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 16, 2026 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 30, 2026 FICS
FINAL DISPOSITION PROCESSED
Mar 30, 2026 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 19, 2025 FICR
NEW REPRESENTATIVE AT IB RECEIVED
Dec 18, 2025 NREP
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 26, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 26, 2024 R.PR
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Nov 3, 2024 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
Jul 23, 2024 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 25, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jun 25, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 5, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 23, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 14, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 13, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
May 13, 2024 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jan 30, 2024 GNFN
FINAL REFUSAL E-MAILED
Jan 30, 2024 GNFR
FINAL REFUSAL WRITTEN
Jan 30, 2024 CNFR
ASSIGNED TO EXAMINER
Jan 30, 2024 DOCK
REFUSAL PROCESSED BY IB
Jul 22, 2023 RFNP
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 15, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 14, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 14, 2023 TROA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 26, 2023 RFCS
REFUSAL PROCESSED BY MPU
Jun 25, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 19, 2023 RFCR
NON-FINAL ACTION WRITTEN
May 18, 2023 CNRT
ASSIGNED TO EXAMINER
May 12, 2023 DOCK
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 17, 2023 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 17, 2023 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jan 17, 2023 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 17, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 17, 2023 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 17, 2023 COAR
APPLICATION FILING RECEIPT MAILED
Dec 27, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 23, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 22, 2022 REPR